Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-271924
Filing Date
2021-09-13
Accepted
2021-09-13 21:46:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10906
2 GRAPHIC g111280dsp01.jpg GRAPHIC 4038
  Complete submission text file 0001193125-21-271924.txt   17627
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)